ArticleBMC nephrology2025

Treatment options for patients with high anti-PLA2R antibodies in primary membranous nephropathy: a single-center cohort retrospective study.

Huiling Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.